Company:  SELECTA BIOSCIENCES INC (SELB)
Form Type:  10-Q
Filing Date:  8/6/2020 
CIK:  0001453687 
Address:  65 GROVE STREET 
City, State, Zip:  WATERTOWN, Massachusetts 02472 
Telephone:  617-923-1400 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$2.96  
Change: 
-0.28 (-8.64%)  
Trade Time: 
Oct 30  
Market Cap: 
$317.14M
Trade SELB now with 

© 2020  
Description of Business
We are a clinical-stage biopharmaceutical company using our ImmTOR(TM) platform, designed to induce tolerance to novel biologic therapies that would otherwise be limited by immunogenicity with the goal of effectively and safely treating rare and serious diseases. Many such diseases are treated with biologic therapies that are foreign to the patient's immune system and therefore elicit an undesired immune response. Of particular concern are anti-drug antibodies, or ADAs, which are often produced by the immune system in response to biologic therapy and can adversely affect the efficacy and safety of treatment. Our proprietary tolerogenic ImmTOR platform encapsulates an immunomodulator in biodegradable nanoparticles and is designed to mitigate the formation of ADAs by inducing antigen-specific immune tolerance to biologic drugs.
Register and access this filing in:     
  FORM 10-Q
    PART I - FINANCIAL INFORMATION
      FINANCIAL STATEMENTS
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        CASH FLOW
        Notes to Consolidated Financial Statements (Unaudited)
          CASH FLOW
          CASH FLOW
      Item 3. Quantitative and Qualitative Disclosures About ...
      Item 4. Controls and Procedures
    PART II-OTHER INFORMATION
      Item 1. Legal Proceedings
      Item 2. Unregistered Sales of Equity Securities and Use of ...
      Item 3. Defaults upon Senior Securities
      Item 4. Mine Safety Disclosures
      Item 5. Other Information
      Item 6. Exhibits
    EXHIBIT INDEX
    SIGNATURES
  EXHIBIT 4.1
  EXHIBIT 10.1
  EXHIBIT 10.2
  EXHIBIT 10.3
  EXHIBIT 31.1
    CERTIFICATIONS
  EXHIBIT 31.2
    CERTIFICATIONS
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO
  EXHIBIT 32.2
    CERTIFICATION PURSUANT TO